ocular, umbilical, kidney, bone-joint, and meningeal) are common in the newborn period.
Infection may be acquired in utero through the
transplacental or trans-cervical routes and during or after birth. Ascending infection through the cervix, with or without rupture of the amniotic fluid membranes, may result in amnionitis, funisitis (infection of the umbilical cord), congenital pneumonia, and sepsis. The bacteria responsible for ascending infection of the fetus are common bacterial organisms of the maternal geni-tourinary tract, such as group B streptococci, E. coli, Haemophilus influenzae, and Klebsiella.
Herpes simplex virus (HSV)-1 or more often HSV-2 also
causes ascending infection that at times may be indistinguishable from bacterial sepsis.
Syphilis and Listeria monocytogenes are acquired by
transplacental infection. Maternal humoral immunity may protect the fetus against some neonatal pathogens, such as group B streptococci and HSV.
Nonetheless, various deficiencies of the neonatal
antimicrobial defense mechanism probably are more important than maternal immune status as a contributing factor for neonatal infection, especially in the LBW infant. Preterm infants before 32 weeks of gestational age have not received the full complement of maternal antibodies (IgG), which cross the placenta by active transport predominantly in the latter half of the third trimester.
In addition, although LBW infants may generate
IgM antibodies, their own IgG response to infection is reduced. These infants also have deficiencies of the alternate and, to a smaller degree, the classic complement activation pathways, which results in diminished complement- mediated opsonization.
Newborn infants also show a deficit in phagocytic
migration to the site of infection (to the lung) and in the bone marrow reserve pool of leukocytes. In addition, in the presence of suboptimal activation of complement, neonatal neutrophils ingest and kill bacteria less effectively than adult neutrophils do. Bacterial sepsis and meningitis often are linked closely in neonates.
Despite this association, the incidence of meningitis
relative to neonatal sepsis has been on a steady decline. The incidence of meningitis is approximately 1 in 20 cases of sepsis.
The causative organisms isolated most frequently are
the same as for neonatal sepsis: group B streptococci, E. coli, and L. monocytogenes. Gram-negative organisms, such as Klebsiella and Serratia marcescens, are more common in less developed countries, and coagulase-negative staphylococci need to be considered in VLBW infants. Male infants seem to be more susceptible to neonatal infection than female infants. Severely premature infants are at even greater risk secondary to less effective defense mechanisms and deficient transfer of antibodies from the mother to the fetus (which occurs mostly after 32 weeks' gestation). Neonatal sepsis presents during three periods. Early-onset sepsis:
often begins in utero and usually is a result of infection
caused by the bacteria in the mother's genitourinary tract. Organisms related to this sepsis include group B streptococci, E. coli, Klebsiella, L. monocytogenes, and nontypable H. influenzae. Most infected infants are premature and show nonspecific cardiorespiratory signs, such as grunting, tachypnea, and cyanosis at birth. Risk factors for early-onset sepsis include vaginal colonization with group B streptococci, prolonged rupture of the membranes (>24 hours), amnionitis, maternal fever or leukocytosis, fetal tachycardia, and preterm birth.
African American race and male sex are unexplained
additional risk factors for neonatal sepsis Early-onset sepsis (birth to 7 days) is an overwhelming multiorgan system disease frequently manifested as respiratory failure, shock, meningitis (in 30% of cases), DIC, acute tubular necrosis, and symmetric peripheral gangrene.
Early manifestations-grunting, poor feeding, pallor,
apnea, lethargy, hypothermia, or an abnormal cry-may be nonspecific.
Profound neutropenia, hypoxia, and hypotension may be
refractory to treatment with broad-spectrum antibiotics, The clinical manifestations of sepsis are difficult to separate from the manifestations of meningitis in the neonate.
Infants with early-onset sepsis should be evaluated
by blood and CSF cultures, CSF Gram stain, cell count, and protein and glucose levels.
Normal newborns generally have an elevated CSF
protein content (100 to 150 mg/dL) and may have 25 to 30/mm3 white blood cells (mean 9/mm3), which are 75% lymphocytes in the absence of infection. The initial clinical manifestations of nosocomial infection in a premature infant may be subtle and include apnea and bradycardia, temperature instability, abdominal distention, and poor feeding.
In the later stages, signs of infection are shock,
DIC, worsening respiratory status, and local reactions, such as omphalitis, eye discharge, diarrhea, and bullous impetigo. The treatment of nosocomially acquired sepsis depends on the indigenous microbiologic flora of the particular hospital and the antibiotic sensitivities.
Because S. aureus (occasionally methicillin-
resistant), Staphylococcus epidermidis (methicillin- resistant), and gram-negative pathogens are common nosocomial bacterial agents in many nurseries, a combination of vancomycin or oxacillin/nafcillin (some use ampicillin) with an aminoglycoside (gentamicin or tobramycin) is appropriate.